Skip to main content
$166.15 -$5.98 (-3.5%)

04:00 PM EST on 02/25/21

Quidel Corp (NASDAQ:QDEL)

CAPS Rating: 5 out of 5

The Company is engaged in the development, manufacturing and marketing of rapid diagnostic solutions at the professional point-of-care in infectious diseases and reproductive health.

Current Price $166.15 Mkt Cap $7.3B
Open $172.28 P/E Ratio 8.64
Prev. Close $166.15 Div. (Yield) $0.00 (0.0%)
Daily Range $164.50 - $175.50 Volume 838,756
52-Wk Range $72.99 - $306.72 Avg. Daily Vol. 947,124

Caps

How do you think NASDAQ:QDEL will perform against the market?

Add Stock to CAPS Watchlist

All Players

350 Outperform
12 Underperform
 

All-Star Players

117 Outperform
1 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:QDEL Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

kayceygirl (< 20)
Submitted August 14, 2010

This is one of my STARZ.Here is the thought process on this STAR: a) Divided rate over Zerob) 3 Year Beta between -5 & +3c) 15% + Insider ownershipd) No greater than -50% Growth rate for the last 3 years (tough last couple of years so good that… More

MacHolly (< 20)
Submitted April 07, 2020

Price has become too high,,,long way to fall. Check out 10-year chart...

NASDAQ:QDEL VS S&P 500 (SPY)

Fools bullish on NASDAQ:QDEL are also bullish on:

Fools bearish on NASDAQ:QDEL are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about QDEL.

Recs

0
Member Avatar Oranicus (95.81) Submitted: 2/8/2021 3:54:31 PM : Outperform Start Price: $247.61 NASDAQ:QDEL Score: -46.41

Poised to get bigger and bigger.

Recs

0
Member Avatar MujamMojam (< 20) Submitted: 1/29/2021 7:56:10 PM : Outperform Start Price: $251.84 NASDAQ:QDEL Score: -36.33

QDEL is not only about COVID-19 testing but it also has rapid Troponin (Test for Myocardial Infarction or an acute Heart attack detection. Anyone visiting an ER with Chest pain complaints needs three of those tests done. Just look at their EPS of >8.5.. This company is going places

Recs

0
Member Avatar TMFjbonefish (55.19) Submitted: 1/29/2021 10:06:51 AM : Outperform Start Price: $260.46 NASDAQ:QDEL Score: -37.95

Due to COVID testing, third-quarter revenue increased 276% year over year to $461 million. Before COVID, sales had grown from $192 million in 2016 to $535 million in 2019, and its Savanna testing device -- a mid-2021 planned launch -- offers another avenue for growth in the $8.6 billion molecular diagnostics market.

Leaderboard

Find the members with the highest scoring picks in QDEL.

Score Leader

robertsylvia

robertsylvia (< 20) Score: +1,626.85

The Score Leader is the player with the highest score across all their picks in QDEL.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
WildCAPS 80.96 3/17/2009 Outperform 3M $7.77 +2,038.35% +411.50% +1,626.85 0 Comment
robertsylvia < 20 3/17/2009 Outperform NS $7.77 +2,038.35% +411.50% +1,626.85 0 Comment
SSPX3 < 20 4/24/2009 Outperform NS $8.50 +1,854.71% +349.08% +1,505.63 0 Comment
saaf569 60.76 3/23/2009 Outperform 3Y $8.59 +1,834.23% +390.63% +1,443.59 0 Comment
jygalye 49.54 2/27/2007 9/13/2008 Outperform 1Y $10.36 +1,503.76% +182.63% +1,321.13 0 Comment
danonwilfon 56.24 3/1/2007 Outperform 3M $10.65 +1,460.09% +191.24% +1,268.86 0 Comment
MrProbabilistic 24.62 3/9/2007 Outperform NS $10.84 +1,432.75% +187.17% +1,245.58 1 Comment
acf8vj < 20 3/12/2007 Outperform 3M $11.04 +1,404.98% +188.61% +1,216.37 0 Comment
withoutlimits 84.49 4/27/2009 Outperform 5Y $10.03 +1,556.53% +348.52% +1,208.01 1 Comment
sandrick 80.70 4/28/2009 Outperform 3W $10.11 +1,543.42% +354.63% +1,188.79 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for QDEL.